| Filed On | Filing |
|---|---|
| 24 Sep 2025 |
Form 3: Dearen Danny L., Director
Holds 58,017 shares of Common Stock |
| 01 Aug 2025 |
Form 3: Cohen Raymond W, Director
Holds 48,387 shares of Common Stock |
| 26 Jun 2025 |
Form 3: Lawless Michael A, Chief Financial Officer
Holds 465,000 shares of Common Stock |
| 27 Nov 2024 |
Form 3: Ward Scott R., Director
Holds 43,548 shares of Common Stock |
| 10 Oct 2023 |
Form 3: Verta Patrick, EVP Clinical/Medical Affairs
Holds 142,740 shares of Common Stock |
| 20 Mar 2023 |
Form 3: Tommasoli Andrea, Chief Operating Officer
Holds 18,103 shares of Common Stock |
| 01 Mar 2023 |
Form 3: Gleason Shane Thomas, VP Global Marketing
No securities owned |
| 12 May 2021 |
Form 3: Arnold Kathryn, Director
No securities owned |
| 16 Oct 2020 |
Form 3: Roubin Gary S, Director
Holds 238,950 shares of Common Stock |
| 03 Jan 2020 |
Form 3: Slosman Marvin, Director
No securities owned |
| 26 Oct 2016 |
Form 3: Gago Agustin V, EVP, Chief Commercial Officer
No securities owned |
| 08 Sep 2016 |
Form 3: Kester Thomas J, Director
Holds 7,000 shares of Common Stock |
| 26 Jan 2016 |
Form 3: Blech Isaac, Director
No securities owned |
| 05 Dec 2013 |
Form 3: Olson Eric L., VP of Global Sales Operations
No securities owned |
| 05 Sep 2013 |
Form 3: Rogers Campbell, Director
No securities owned |
| 11 Feb 2013 |
Form 3: Berman Michael, Director
No securities owned |
| 07 Jan 2013 |
Form 3: Milinazzo Alan, Director
No securities owned |
| 09 Nov 2012 | Form 3: Bar Eli, CTO InspireMD Ltd. |
| 09 Nov 2012 |
Form 3: Ratini Robert, VP Sales Mkting InspireMD Ltd.
No securities owned |
| 25 Sep 2012 |
Form 3: Loughlin James J, Director
No securities owned |
Loading...